Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Date: July 1, 2011
Pages: 88
Price:
US$ 3,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B59141F1AC5EN
Leaflet:

Download PDF Leaflet

Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Summary

GlobalData’s new report, “Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global bone graft substitutes market. The report provides market landscape, competitive landscape and market trends information on the bone graft substitutes market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include BMP and Synthetic Bone Graft Substitutes.
  • Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within bone graft substitutes market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, Stryker/Olympus, DePuy, Synthes and Orthovita.

Reasons to buy
  • Develop business strategies by understanding the trends and developments that are driving the bone graft substitutes market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What’s the next big thing in the bone graft substitutes market landscape? – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global bone graft substitutes market and the factors shaping it.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 GlobalData Report Guidance

3 BONE GRAFT SUBSTITUTES - DEVICE OVERVIEW

3.1 Bone Morphogenetic Proteins
3.2 Synthetic Bone Graft Substitutes
3.3 Demineralized Bone Matrix (DBM)
3.4 Bone Graft Substitutes Applications
  3.4.1 Spinal Fusion
  3.4.2 Fractures and Bone Injuries
  3.4.3 Foot and Ankle Surgery
  3.4.4 Hip Surgery

4 BONE GRAFT SUBSTITUTES - MARKET CHARACTERIZATION

4.1 Bone Graft Substitutes Market, Global, Revenue ($m), Historic, 2003-2010
4.2 Bone Graft Substitutes Market, Global, Revenue ($m), Forecast, 2010-2017
4.3 Bone Graft Substitutes Market, Key Trends
  4.3.1 Increase in the Number of Mergers and Acquisitions Pointing to High Growth Potential of the Bone Graft Substitute Market
  4.3.2 Evolving New Technologies to Impact the Market Landscape of the Bone Graft Substitutes Market
4.4 Bone Graft Substitutes, Market Dynamics
  4.4.1 Market Drivers
  4.4.2 Market Restraints

5 BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, REVENUE ($M), 2003–2017

5.1 Bone Graft Substitutes Market, the US, Revenue ($m), by Segment, Historic, 2003–2010
5.2 Bone Graft Substitutes Market, the US, Revenue ($m), by Segment, Forecast, 2010–2017
5.3 Bone Graft Substitutes Market, Canada, Revenue ($m), by Segment, Historic, 2003–2010
5.4 Bone Graft Substitutes Market, Canada, Revenue ($m), by Segment, Forecast, 2010–2017
5.5 Bone Graft Substitutes Market, the UK, Revenue ($m), by Segment, Historic, 2003–2010
5.6 Bone Graft Substitutes Market, the UK, Revenue ($m), by Segment, Forecast, 2010–2017
5.7 Bone Graft Substitutes Market, Germany, Revenue ($m), by Segment, Historic, 2003–2010
5.8 Bone Graft Substitutes Market, Germany, Revenue ($m), by Segment, Forecast, 2010–2017
5.9 Bone Graft Substitutes Market, France, Revenue ($m), by Segment, Historic, 2003–2010
5.10 Bone Graft Substitutes Market, France, Revenue ($m), by Segment, Forecast, 2010–2017
5.11 Bone Graft Substitutes Market, Italy, Revenue ($m), by Segment, Historic, 2003–2010
5.12 Bone Graft Substitutes Market, Italy, Revenue ($m), by Segment, Forecast, 2010–2017
5.13 Bone Graft Substitutes Market, Spain, Revenue ($m), by Segment, Historic, 2003–2010
5.14 Bone Graft Substitutes Market, Spain, Revenue ($m), by Segment, Forecast, 2010–2017
5.15 Bone Graft Substitutes Market, Japan, Revenue ($m), by Segment, Historic, 2003–2010
5.16 Bone Graft Substitutes Market, Japan, Revenue ($m), by Segment, Forecast, 2010–2017
5.17 Bone Graft Substitutes Market, China, Revenue ($m), by Segment, Historic, 2003–2010
5.18 Bone Graft Substitutes Market, China, Revenue ($m), by Segment, Forecast, 2010–2017
5.19 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, Historic, 2003–2010
5.20 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, Forecast, 2010–2017
5.21 Bone Graft Substitutes Market, Australia, Revenue ($m), by Segment, Historic, 2003–2010
5.22 Bone Graft Substitutes Market, Australia, Revenue ($m), by Segment, Forecast, 2010–2017
5.23 Bone Graft Substitutes Market, Brazil, Revenue ($m), by Segment, Historic, 2003–2010
5.24 Bone Graft Substitutes Market, Brazil, Revenue ($m), by Segment, Forecast, 2010–2017

6 BONE GRAFT SUBSTITUTES MARKET - STRATEGIC COMPETITIVE ASSESSMENT

6.1 Bone Graft Substitutes Market, Global, Company Share (%), 2010
6.2 Bone Graft Substitutes Market - Key Player Profiles
  6.2.1 Medtronic
  6.2.2 Synthes
  6.2.3 Wright Medical
  6.2.4 Orthovita
  6.2.5 Stryker/ Stryker-Olympus
  6.2.6 Osteotech

7 BONE GRAFT SUBSTITUTES MARKET - STRATEGIC PIPELINE ASSESSMENT

7.1 Synthetic Bone Graft Substitutes, Pipeline Products
7.2 Bone Morphogenetic Proteins, Pipeline Products
7.3 Demineralized Bone Matrix and Anorganic Bone Matrix, Pipeline Products
7.4 Profiles of Promising Products Under Clinical Development
  7.4.1 AMPLEX Osteo-Promotive Bone Graft System
  7.4.2 Augment Bone Graft
  7.4.3 BioChaperone BMP
  7.4.4 BMP-7
  7.4.5 i-FACTOR Flex
7.5 Profiles of Pipeline Products Based on New Technologies
  7.5.1 Hyalonect
  7.5.2 Ceramic ElutiBone
  7.5.3 SeriACL Scaffold
  7.5.4 ST01 Bone Graft Substitute Material

8 BONE GRAFT SUBSTITUTES MARKET - M&A LANDSCAPE

8.1 Bone Graft Substitutes, Major Mergers and Acquisitions, Deal Value, 2007-2011
8.2 Bone Graft Substitutes, Key Partnership Deals, 2007-2011
8.3 Key Acquisitions
  8.3.1 Stryker Completes Acquisition of Orthovita
  8.3.2 Johnson & Johnson Enters Into an Agreement to Acquire Synthes
  8.3.3 OLYMPUS Completes Acquisition of OP-1 Product Line from Stryker
  8.3.4 Medtronic Completes Acquisition of Osteotech
  8.3.5 Baxter International Completes Acquisition of ApaTech
  8.3.6 TiGenix Completes Acquisition of OrthoMimetics
  8.3.7 Alynx Acquires MiMedx
  8.3.8 Integra LifeSciences Holdings Acquires IsoTis

9 APPENDIX

9.1 Definitions
  9.1.1 Bone Graft Substitutes
9.2 Acronyms
9.3 Research Methodology
  9.3.1 Secondary Research
  9.3.2 Primary Research
  9.3.3 Models
  9.3.4 Forecasts
  9.3.5 Expert Panels
9.4 GlobalData Consulting
9.5 Contact Us
9.6 Disclaimer
9.7 Sources 88

LIST OF TABLES

Table 1: Bone Graft Substitutes Market, Global, Revenue ($m), 2003-2010
Table 2: Bone Graft Substitutes Market, Global, Revenue ($m), 2010-2017
Table 3: Bone Graft Substitutes Market, Key Acquisitions, 2010-2011
Table 4: Percentage of Population aged 65 Years and Older, by Country, 2005-2015
Table 5: Orthopedic Procedures (‘000), Age Wise Distribution, the US, 1990-2007
Table 6: Sports Related Trauma Injuries (‘000), the US, 2007-2009
Table 7: Bone Graft Substitutes, Procedures (%), By Usage, Global, 2010
Table 8: Bone Morphogenetic Proteins, Clinical Trials
Table 9: Synthetic Bone Graft Substitutes, Clinical Trials
Table 10: DBM, Clinical Trials
Table 11: Center for Medicare and Medicaid Services (CMS) Disbursements for Orthopedic Procedures, the US, 2010
Table 12: Bone Graft Substitutes, Average Selling Price ($), the US, 2003-2010
Table 13: Bone Graft Substitutes Market, the US, Revenue ($m), 2003–2010
Table 14: Bone Graft Substitutes Market, the US, Revenue ($m), 2010–2017
Table 15: Bone Graft Substitutes Market, Canada, Revenue ($m), 2003-2010
Table 16: Bone Graft Substitutes Market, Canada, Revenue ($m), 2010–2017
Table 17: Bone Graft Substitutes Market, the UK, Revenue ($m), 2003–2010
Table 18: Bone Graft Substitutes Market, the UK, Revenue ($m), 2010–2017
Table 19: Bone Graft Substitutes Market, Germany, Revenue ($m), 2003–2010
Table 20: Bone Graft Substitutes Market, Germany, Revenue ($m), 2010–2017
Table 21: Bone Graft Substitutes Market, France, Revenue ($m), 2003–2010
Table 22: Bone Graft Substitutes Market, France, Revenue ($m), 2010–2017
Table 23: Bone Graft Substitutes Market, Italy, Revenue ($m), 2003–2010
Table 24: Bone Graft Substitutes Market, Italy, Revenue ($m), 2010–2017
Table 25: Bone Graft Substitutes Market, Spain, Revenue ($m), 2003–2010
Table 26: Bone Graft Substitutes Market, Spain, Revenue ($m), 2010–2017
Table 27: Bone Graft Substitutes Market, Japan, Revenue ($m), 2003–2010
Table 28: Bone Graft Substitutes Market, Japan, Revenue ($m), 2010–2017
Table 29: Bone Graft Substitutes Market, China, Revenue ($m), 2003–2010
Table 30: Bone Graft Substitutes Market, China, Revenue ($m), 2010–2017
Table 31: Bone Graft Substitutes Market, India, Revenue ($m), 2003–2010
Table 32: Bone Graft Substitutes Market, India, Revenue ($m), 2010–2017
Table 33: Bone Graft Substitutes Market, Australia, Revenue ($m), 2003–2010
Table 34: Bone Graft Substitutes Market, Australia, Revenue ($m), 2010–2017
Table 35: Bone Graft Substitutes Market, Brazil, Revenue ($m), 2003–2010
Table 36: Bone Graft Substitutes Market, Brazil, Revenue ($m), 2010–2017
Table 37: Bone Graft Substitutes Market, Global, Company Share (%), 2010
Table 38: Medtronic, Inc., Key Marketed Products, 2011
Table 39: Medtronic, Inc., Key Pipeline Products, 2011
Table 40: Synthes, Key Marketed Products, 2011
Table 41: Wright Medical, Key Marketed Products, 2011
Table 42: Wright Medical, Key Pipeline Products, 2011
Table 43: Orthovita, Key Marketed Products, 2011
Table 44: Orthovita, Key Pipeline Products, 2011
Table 45: Stryker/Stryker-OLYMPUS, Key Marketed Products, 2011
Table 46: Stryker/Stryker-OLYMPUS, Key Pipeline Products, 2011
Table 47: Osteotech, Key Marketed Products, 2011
Table 48: Bone Graft Substitutes, Pipeline Products, Percentage by Development Stage, 2010
Table 49: Synthetic Bone Graft Substitutes, Pipeline Products, 2010
Table 50: Bone Morphogenetic Proteins, Pipeline Products, Global, 2011
Table 51: Demineralized Bone Matrix and Anorganic Bone Matrix, Pipeline Products, Global, 2011
Table 52: AMPLEX Osteo-Promotive Bone Graft System, Status, 2010
Table 53: AMPLEX Osteo-Promotive Bone Graft System, Description, 2010
Table 54: AMPLEX Osteo-Promotive Bone Graft System, Clinical Trial 1, 2010
Table 55: AMPLEX Osteo-Promotive Bone Graft System, Clinical Trial 2, 2010
Table 56: Augment Bone Graft, Status, 2010
Table 57: Augment Bone Graft, Description, 2010
Table 58: Augment Bone Graft, Clinical Trial 1, 2010
Table 59: Augment Bone Graft, Clinical Trial 2, 2010
Table 60: BioChaperone BMP, Status, 2010
Table 61: BioChaperone, Description, 2010
Table 62: BMP-7, Status, 2010
Table 63: BMP-7, Description, 2010
Table 64: i-FACTOR Flex, Status, 2010
Table 65: i-FACTOR Flex, Description, 2010
Table 66: Hyalonect, Status, 2010
Table 67: Hyalonect, Description, 2010
Table 68: Ceramic ElutiBone, Status, 2010
Table 69: Ceramic ElutiBone, Description, 2010
Table 70: SeriACL Scaffold, Status, 2010
Table 71: SeriACL Scaffold, Description, 2010
Table 72: ST01 Bone Graft Substitute Material, Status, 2010
Table 73: ST01 Bone Graft Substitute Material, Description, 2010
Table 74: Bone Graft Substitutes, Deals, by Type of Deal, 2007-2011*
Table 75: Bone Graft Substitutes, Major Mergers and Acquisitions, Deal Value, 2007-2011*
Table 76: Bone Graft Substitutes, Key Partnership Deals, 2007-2011* 78

LIST OF FIGURES

Figure 1: Bone Graft Substitutes Market, Global, Revenue ($m), 2003-2010
Figure 2: Bone Graft Substitutes Market, Global, Revenue ($m), 2010-2017
Figure 3: Bone Graft Substitutes, Market Dynamics
Figure 4: Orthopedic Procedures (‘000), Age Wise Distribution, the US, 1990-2007
Figure 5: Sports Related Trauma Injuries (‘000), the US, 2007-2009
Figure 6: Bone Graft Substitutes, Procedures (%), By Usage, Global, 2010
Figure 7: Bone Graft Substitutes, Average Selling Price ($), the US, 2003-2010
Figure 8: Bone Graft Types, Evidence in Support of Properties, 2010
Figure 9: Bone Graft Substitutes Market, the US, Revenue ($m), 2003–2010
Figure 10: Bone Graft Substitutes Market, the US, Revenue ($m), 2010–2017
Figure 11: Bone Graft Substitutes Market, Canada, Revenue ($m), 2003–2010
Figure 12: Bone Graft Substitutes Market, Canada, Revenue ($m), 2010–2017
Figure 13: Bone Graft Substitutes Market, the UK, Revenue ($m), 2003–2010
Figure 14: Bone Graft Substitutes Market, the UK, Revenue ($m), 2010–2017
Figure 15: Bone Graft Substitutes Market, Germany, Revenue ($m), 2003–2010
Figure 16: Bone Graft Substitutes Market, Germany, Revenue ($m), 2010–2017
Figure 17: Bone Graft Substitutes Market, France, Revenue ($m), 2003–2010
Figure 18: Bone Graft Substitutes Market, France, Revenue ($m), 2010–2017
Figure 19: Bone Graft Substitutes Market, Italy, Revenue ($m), 2003–2010
Figure 20: Bone Graft Substitutes Market, Italy, Revenue ($m), 2010–2017
Figure 21: Bone Graft Substitutes Market, Spain, Revenue ($m), 2003–2010
Figure 22: Bone Graft Substitutes Market, Spain, Revenue ($m), 2010–2017
Figure 23: Bone Graft Substitutes Market, Japan, Revenue ($m), 2003–2010
Figure 24: Bone Graft Substitutes Market, Japan, Revenue ($m), 2010–2017
Figure 25: Bone Graft Substitutes Market, China, Revenue ($m), 2003–2010
Figure 26: Bone Graft Substitutes Market, China, Revenue ($m), 2010–2017
Figure 27: Bone Graft Substitutes Market, India, Revenue ($m), 2003–2010
Figure 28: Bone Graft Substitutes Market, India, Revenue ($m), 2010–2017
Figure 29: Bone Graft Substitutes Market, Australia, Revenue ($m), 2003–2010
Figure 30: Bone Graft Substitutes Market, Australia, Revenue ($m), 2010–2017
Figure 31: Bone Graft Substitutes Market, Brazil, Revenue ($m), 2003–2010
Figure 32: Bone Graft Substitutes Market, Brazil, Revenue ($m), 2010–2017
Figure 33: Bone Graft Substitutes Market, Global, Company Share (%), 2010
Figure 34: Bone Graft Substitutes, Pipeline Products, Percentage by Development Stage, 2010
Figure 35: Bone Graft Substitutes, Deals, by Type of Deal, 2007-2011* 77

COMPANIES MENTIONED

Medtronic
Synthes
Wright Medical
Orthovita
Stryker/ Stryker-Olympus
Osteotech

Ask Your Question

Bone Graft Substitutes - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: